Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

109 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Identification and expansion of human colon-cancer-initiating cells.
Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R. Ricci-Vitiani L, et al. Nature. 2007 Jan 4;445(7123):111-5. doi: 10.1038/nature05384. Epub 2006 Nov 19. Nature. 2007. PMID: 17122771
The ENETS TNM staging and grading system accurately predict prognosis in patients with rectal NENs.
Capurso G, Gaujoux S, Pescatori LC, Panzuto F, Panis Y, Pilozzi E, Terris B, de Mestier L, Prat F, Rinzivillo M, Coriat R, Coulevard A, Delle Fave G, Ruszniewski P. Capurso G, et al. Among authors: pilozzi e. Dig Liver Dis. 2019 Dec;51(12):1725-1730. doi: 10.1016/j.dld.2019.07.011. Epub 2019 Aug 9. Dig Liver Dis. 2019. PMID: 31405587 Clinical Trial.
Identification and expansion of the tumorigenic lung cancer stem cell population.
Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C, De Maria R. Eramo A, et al. Cell Death Differ. 2008 Mar;15(3):504-14. doi: 10.1038/sj.cdd.4402283. Epub 2007 Nov 30. Cell Death Differ. 2008. PMID: 18049477
New models for cancer research: human cancer stem cell xenografts.
Baiocchi M, Biffoni M, Ricci-Vitiani L, Pilozzi E, De Maria R. Baiocchi M, et al. Curr Opin Pharmacol. 2010 Aug;10(4):380-4. doi: 10.1016/j.coph.2010.05.002. Epub 2010 Jun 17. Curr Opin Pharmacol. 2010. PMID: 20561817 Review.
Thymosin beta4 targeting impairs tumorigenic activity of colon cancer stem cells.
Ricci-Vitiani L, Mollinari C, di Martino S, Biffoni M, Pilozzi E, Pagliuca A, de Stefano MC, Circo R, Merlo D, De Maria R, Garaci E. Ricci-Vitiani L, et al. FASEB J. 2010 Nov;24(11):4291-301. doi: 10.1096/fj.10-159970. Epub 2010 Jun 21. FASEB J. 2010. PMID: 20566622
Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy.
Bartucci M, Svensson S, Romania P, Dattilo R, Patrizii M, Signore M, Navarra S, Lotti F, Biffoni M, Pilozzi E, Duranti E, Martinelli S, Rinaldo C, Zeuner A, Maugeri-SaccĂ  M, Eramo A, De Maria R. Bartucci M, et al. Cell Death Differ. 2012 May;19(5):768-78. doi: 10.1038/cdd.2011.170. Epub 2011 Nov 25. Cell Death Differ. 2012. PMID: 22117197 Free PMC article.
TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells.
Bartucci M, Dattilo R, Moriconi C, Pagliuca A, Mottolese M, Federici G, Benedetto AD, Todaro M, Stassi G, Sperati F, Amabile MI, Pilozzi E, Patrizii M, Biffoni M, Maugeri-SaccĂ  M, Piccolo S, De Maria R. Bartucci M, et al. Oncogene. 2015 Feb 5;34(6):681-90. doi: 10.1038/onc.2014.5. Epub 2014 Feb 17. Oncogene. 2015. PMID: 24531710
Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer.
Sette G, Salvati V, Mottolese M, Visca P, Gallo E, Fecchi K, Pilozzi E, Duranti E, Policicchio E, Tartaglia M, Milella M, De Maria R, Eramo A. Sette G, et al. Cell Death Dis. 2015 Aug 6;6(8):e1850. doi: 10.1038/cddis.2015.217. Cell Death Dis. 2015. PMID: 26247735 Free PMC article.
Cancer Stem Cell-Based Models of Colorectal Cancer Reveal Molecular Determinants of Therapy Resistance.
De Angelis ML, Zeuner A, Policicchio E, Russo G, Bruselles A, Signore M, Vitale S, De Luca G, Pilozzi E, Boe A, Stassi G, Ricci-Vitiani L, Amoreo CA, Pagliuca A, Francescangeli F, Tartaglia M, De Maria R, Baiocchi M. De Angelis ML, et al. Stem Cells Transl Med. 2016 Apr;5(4):511-23. doi: 10.5966/sctm.2015-0214. Epub 2016 Mar 8. Stem Cells Transl Med. 2016. PMID: 26956206 Free PMC article.
109 results
Jump to page
Feedback